Eisai (pronounced ‘ā-zī’) is derived from the Japanese word for ‘health product’ and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. We place primary emphasis on patients and their families, and observe the highest legal and ethical standards in our business activities.
Eisai is one of the world’s leading research-based pharmaceutical companies. We define our corporate mission as “giving first thought to patients and their families, and to increasing the benefits health care provides,” which we call human health care (hhc). With operations in the U.S., Asia, Europe and its domestic home market of Japan, Eisai employs more than 11,000 people worldwide.
Eisai focuses its efforts in several therapeutic areas; here in Australia, Neurology and Oncology are our primary specialty areas.